Why take the continuous route? Because it leads to better, faster bioprocessing.
Sponsored By
Why adopt continuous bioprocessing? Because it can lead to faster and more cost-effective biopharma manufacturing. In this supplement, Pall and their collaborators discuss the benefits of continuous bioprocessing and how Pall is innovating in this area.
Receive the latest analytical science news, personalities, education, and career development – weekly to your inbox.
May 27, 2025
6 min read
Audrey Greenberg’s latest insight on US-based manufacturing, Trump’s “Administration for A Healthy America”, and an ever-shifting regulatory environment.
December 1, 2014
0 min read
Upstream processes in biopharma manufacturing are growing ever more efficient; conversely, downstream processing is increasingly a bottleneck. Can a new generation of chromatography techniques and technologies get things moving again?
May 7, 2025
5 min read
Off-the-shelf allogeneic CAR-Ts, increased manufacturing productivity led by digital systems, and more; we ask experts about the future of advanced medicine.
April 7, 2025
6 min read
Meet one company and its new drug candidate in the fight against gram-negative bacterial infections.